Remarkables Capital is a London- & U.S.-based investment and advisory firm.

SaniMed Science Group is a global health-tech investment and commercialization firm focused on Biotech, MedTech, TechBio, and AI-enabled healthcare innovations. We invest in and partner with early- an ...

BIOIO is a therapeutics company developing first-in-class gerotherapies for aging-related diseases like T2DM. Its MOAT platform combines genome-wide screening, AI modeling, and in silico docking to un ...

Cilcare is a US–French biotech company pioneering auditory sciences to advance the detection and treatment of hearing disorders, now recognized as the leading modifiable risk factor for dementia.Its l ...

Coastar Therapeutics is a San Diego based company developing in vivo systemic and redosable gene delivery technology based on purified cell membrane as gene carrier. Coastar's mission is to break the ...

To create a healthier future for patients with life-threatening diseases, we are using our pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in ...

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid maligna ...

Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet ...

Immunis is a clinical stage regenerative medicine biotech developing a unique stem cell-derived biologic, a novel multi-active therapy targeting dysregulated immune-associated muscle aging and metabol ...

NewYorkBIO brings together over 250 of New York’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization. We are the l ...